Based
on the 2013 version, this update Report provides detailed analysis on Chinese
government policies about dialysis industry and the relevant effect in recent
three years, and conducts in-depth research about dialysis industry
segmentations. Moreover, it analyzes Chinese private-owned hemodialysis
services.
In
the aspect of enterprises, this update Report not only updates the latest
information about the key enterprises listed in 2013 version, but also adds the
information about some enterprises who intend to enter into this industry. This
update Report reflects an overall development situation of China's dialysis
industry and provides references for investors and entrepreneurs.
In
China, hemodialysis treatment has gained a wide popularity. By the end of 2013,
the number of dialysis centers has amounted to 3637, contributing a make scale
of CNY 14.4 billion, in which, hemodialysis was CNY 11.5 billion, and
peritoneal dialysis was CNY 2.9 billion.
Access This Full Report @ http://www.radiantinsights.com/research/research-and-development-prospect-of-china-dialysis-market-2014-2018
Foreign
enterprises, such as, Germany Fresenius, Japan Nikkiso and Asahi Kasei, have
dominated China's dialysis market. Chinese enterprises mainly are engaged in
the production of dialysis tubing or dialysate and other low technology content
products. And few Chinese enterprises are specialized in manufacturing dialysis
machines and dialyzers or other high end products.
Now
the situation improved a little, Chinese enterprise Weigao has led China's
hemodialysis machines and dialyzers manufacture, and Chinese enterprise Huaren
Pharma has led China's peritoneal dialysis industry.
By
the end of May 2014, rural residence critical illness insurance program has
already covered over 50% counties (cities and districts) in whole China. And in
Shandong, Tianjin, Jilin, Gansu, and Qinghai, and some other cities and provinces,
the critical illness insurance program is in full swing, and the provincial
government has implemented the overall planning in each administrative region.
Huidian
Research believes that along with the gradual implementation of critical
illness program in China, more and more ESRD (End Stage Renal Disease) patients
will enjoy the insurance guarantee. Therefore, China's dialysis industry is
entering into golden development stage.
About Us
Radiant Insights is a platform for companies looking to meet their
market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
No comments:
Post a Comment